IFM Investors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.99M | Buy |
13,681
+828
| +6% | +$181K | 0.03% | 453 |
|
|
2025
Q1 | $2.88M | Sell |
12,853
-256
| -2% | -$57.3K | 0.03% | 447 |
|
|
2024
Q4 | $4.29M | Sell |
13,109
-1,414
| -10% | -$463K | 0.04% | 366 |
|
|
2024
Q3 | $4.36M | Sell |
14,523
-87
| -0.6% | -$26.1K | 0.04% | 380 |
|
|
2024
Q2 | $4.81M | Buy |
14,610
+47
| +0.3% | +$15.5K | 0.05% | 348 |
|
|
2024
Q1 | $5.76M | Buy |
14,563
+112
| +0.8% | +$44.3K | 0.06% | 304 |
|
|
2023
Q4 | $5.09M | Buy |
14,451
+178
| +1% | +$62.7K | 0.06% | 300 |
|
|
2023
Q3 | $5.36M | Buy |
14,273
+548
| +4% | +$206K | 0.07% | 279 |
|
|
2023
Q2 | $5.25M | Buy |
13,725
+196
| +1% | +$75K | 0.07% | 291 |
|
|
2023
Q1 | $4.69M | Buy |
13,529
+215
| +2% | +$74.5K | 0.07% | 298 |
|
|
2022
Q4 | $3.13M | Hold |
13,314
| – | – | 0.05% | 364 |
|
|
2022
Q3 | $3.28M | Buy |
13,314
+526
| +4% | +$129K | 0.06% | 329 |
|
|
2022
Q2 | $3.87M | Buy |
12,788
+1,654
| +15% | +$500K | 0.07% | 302 |
|
|
2022
Q1 | $4.57M | Buy |
11,134
+1,682
| +18% | +$691K | 0.07% | 281 |
|
|
2021
Q4 | $4.43M | Sell |
9,452
-128
| -1% | -$60K | 0.08% | 249 |
|
|
2021
Q3 | $4.07M | Buy |
9,580
+34
| +0.4% | +$14.4K | 0.08% | 233 |
|
|
2021
Q2 | $3.43M | Buy |
9,546
+1,251
| +15% | +$449K | 0.07% | 284 |
|
|
2021
Q1 | $2.34M | Buy |
8,295
+1,120
| +16% | +$316K | 0.06% | 314 |
|
|
2020
Q4 | $2.03M | Buy |
7,175
+1,148
| +19% | +$325K | 0.06% | 295 |
|
|
2020
Q3 | $1.66M | Buy |
6,027
+634
| +12% | +$174K | 0.07% | 276 |
|
|
2020
Q2 | $1.23M | Sell |
5,393
-2,425
| -31% | -$551K | 0.06% | 305 |
|
|
2020
Q1 | $1.19M | Buy |
7,818
+2,710
| +53% | +$411K | 0.05% | 338 |
|
|
2019
Q4 | $768K | Buy |
+5,108
| New | +$768K | 0.03% | 533 |
|